Responsible for establishment and support of new products and clinical applications in the oncology NGS market by working closely with oncologists, pathologists and clinical researchers. The Director of Clinical NGS will help expand the global NGS market and gain adoption of PGDx’s tissue and liquid biopsy targeted assays and directly support sales team in technical discussions. The core objective of this position is the cooperation and collaboration with key opinion leaders (KOLs) to ensure that PGDx’s IVD and RUO assays gain uptake in the clinical market space through clinical and enrollment trials and clinical onboarding at medical institution and create market awareness through presentations, publications, webinar and press releases. This will rely heavily on developing and maintaining strong working relationships with both external customers and internal teams to ensure unimpeded flow of information critical to assay success and clinical uptake.
Required Education & Experience
About Personal Genome Diagnostics
Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by internationally-recognized cancer researchers Dr. Luis Diaz and Dr. Victor Velculescu, who are pioneers in the application of innovative genomic technologies for drug development and clinical practice.
Please submit applications (cover letter and resume) to HR@personalgenome.com
Special consideration will be given to internal PGDx employees who apply.